Weight Loss in Superior WI

Semaglutide and Tirzepatide are injectable medications that help with long-term weight loss success. They are part of a class of drugs known as GLP-1 (Glucagon-like peptide 1) receptor agonists. Like a hormone produced in the gut, GLPs assist in appetite control, food cravings, and insulin stabilization while following a weight loss program incorporating lifestyle modification through diet and exercise. The results are excellent. Research statistics show a 10-20% body weight reduction in patients taking GLP medication versus placebo. Available now at Twin Ports Wellness & Aesthetics.

GLP-1/GIP medications are not a fad. They are used as a tool to assist with lifestyle modification for long-term weight management success. Evidence shows that these medications can help you shed pounds consistently with few side effects.

Semaglutide and Tirzepatide’s effectiveness for weight loss is impressive and backed by research. Both have resulted in significant weight loss compared to placebo and even up against other GLP-1 receptor agonists such as Liraglutide. Thus, Semaglutide *appears superior* to various other GLP-1 receptor agonist medications for weight loss, according to a study published in 2019. Additionally, the study found that Semaglutide trials as a weight loss drug exceeded the criterion set forth by the FDA and EMA (European Medicines Agency) for obesity medications.

With weekly injections and healthy lifestyle changes, GLP medications can help you by:

• Decreasing your appetite
• Slowing food digestion in the stomach
• Decreasing body fat percentage
• Lowering HbA1c
• Helps in the treatment of PCOS (polycystic ovarian syndrome)

GLP-1/GIP is a game-changer for the best weight loss results. Individuals are losing 20% of their body weight, nearing the levels obtained by bariatric surgery. Additionally, GLP-1/GIP is suitable for long-term use, a significant advantage over other weight loss medications.

Weight loss recommendations are 1-2 lbs per week or 4 to 8 lbs per month for sustained long-term weight loss. Some lose weight more quickly than others.

Treatment with GLP-1/GIP medications improves body composition by reducing excess body fat and increasing lipolysis, or the breakdown of fat cells, including stubborn abdominal fat. It is important to exercise and maintain/increase lean body mass while taking GLP medications for weight loss.

A healthy, high-protein, high-fiber, well-balanced, 1200-calorie-a-day diet is ideal for individuals taking GLP-1/GIP medications like semaglutide and Tirzepatide.

Those who change their lifestyle and eating habits while on GLP-1/GIP’s are more likely to maintain their weight loss. Failure to introduce and continue healthy habits can lead to weight gain. Obesity and weight management are chronic lifelong diseases for many people, and lifestyle modification is necessary to maintain weight loss after the medication is stopped. Many individuals prefer to continue a maintenance program after weight loss goals are met. Our provider at Twin Ports Wellness and Aesthetics can individualize a plan for you to optimize success.

Weight management is a chronic condition that often requires lifetime management. The medication is only a tool for weight loss and lifestyle changes incorporating a healthy diet and exercise. Twin Ports Wellness & Aesthetics patients are treated from a medical perspective rather than a judgmental perspective regarding lack of willpower or character flaws. As a result, we have a very high success rate in helping patients with long-term weight loss goals.

GLP/GIP medication is not suitable for everyone; it is FDA-approved by prescription for patients who are overweight or obese and have a body mass index (BMI) of 27 or greater. Additional weight-related medical problems such as high blood pressure, type 2 diabetes, or high cholesterol may also indicate whether a person is an appropriate candidate for semaglutide.

The weight loss providers at Twin Ports Wellness & Aesthetics will complete a medical history intake with you, review your current medications, and evaluate lab work, ensuring you are an appropriate candidate for GLP-1/GIP and medication safety.

Possible side effects of Semaglutide include nausea, abdominal pain, constipation, diarrhea, heartburn, excessive feelings of fullness that go beyond the desired results, dizziness or light-headedness, persistent sluggishness, and irritation at the injection site. However, when monitored and managed by a qualified provider, the medication is generally well tolerated with few side effects.

You should not take GLP-1/GIP if you have had an allergic reaction or hypersensitivity to another GLP-1/GIP class medication. Those with a family or personal history of thyroid cancers are not candidates for GLP-1/GIP. Specific history of multiple endocrine neoplasia type 2 (tumors in your glands) or thyroid C cell tumors are not candidates for the medication. Those with a history of pancreatitis and or active gallbladder disease are also cautioned in using these medications.